Literature DB >> 18063200

C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure.

S Del Ry1, M Maltinti, M Cabiati, M Emdin, D Giannessi, M A Morales.   

Abstract

C-type natriuretic peptide (CNP) significantly increases in chronic heart failure (CHF) patients as a function of clinical severity. Aim of this study was to evaluate in CHF patients the relationship between circulating CNP concentrations and echo-Doppler conventional indices of left ventricular (LV) function as well as less load independent parameters as dP/dt. LV ejection fraction (EF), left ventricular end-diastolic dimension (LVEDD) and LV dP/dt were evaluated together with plasma CNP levels in 38 patients with CHF and in 63 controls. CNP levels resulted significantly higher in CHF patients than in controls (7.19+/-0.59 pg/ml vs. 2.52+/-0.12 pg/ml, p<0.0001). A significant correlation between dP/dt and CNP levels (r=-0.61, p<0.0001) was observed. A good correlation with EF (r=-0.55, p<0.001) and a less significant relation with LVEDD (r=0.316, p<0.05) were also reported. When patients were divided according to dP/dt values a very significant difference in CNP levels was observed: Group I (<600, n=25) vs. Group II (>600, n=13): 8.46+/-0.69 and 4.75+/-0.75 pg/ml, respectively, p<0.001. This is the first study that reports a correlation between CNP and dP/dt in CHF patients, thus suggesting a possible role on cardiac contractility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063200     DOI: 10.1016/j.peptides.2007.10.022

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.

Authors:  Faraz Afzal; Eirik Qvigstad; Jan Magnus Aronsen; Lise Román Moltzau; Ivar Sjaastad; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-08       Impact factor: 3.000

2.  Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome.

Authors:  Jing Lin; Zhenhui Han; Hongxia Li; Selena Ying Chen; Xueying Li; Ping Liu; Yuli Wang; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

3.  Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease.

Authors:  Lulu Wang; Wenjin Liu; Yanting Yu; Lei Jiang; Junwei Yang
Journal:  BMC Nephrol       Date:  2018-03-05       Impact factor: 2.388

Review 4.  CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System.

Authors:  Yasuaki Nakagawa; Toshio Nishikimi
Journal:  Biology (Basel)       Date:  2022-06-29

5.  C-type natriuretic Peptide as a surrogate marker in variant angina pectoris.

Authors:  Dong-Hyeon Lee; Ho-Joong Youn; Yun-Seok Choi; Jong-Min Lee; Chul-Soo Park; Hae-Ok Jung; Hui-Kyung Jeon; Man-Young Lee
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.